World Market Outlook for the Organ-based/Targeted Drug Delivery Devices Market for Biologics to 2030
September 08, 2020 04:53 ET
|
Research and Markets
Dublin, Sept. 08, 2020 (GLOBE NEWSWIRE) -- The "Organ-based/Targeted Drug Delivery Devices Market for Biologics (Intra-organ / Intra-tumoral), 2020 - 2030" report has been added to...
World Drug Eluting Balloons (DEBs) Market Analysis 2020 with Profiles of Key Vendors Including B. Braun Melsungen AG, Becton, Dickinson and Co., and Boston Scientific Corp
September 04, 2020 04:44 ET
|
Research and Markets
Dublin, Sept. 04, 2020 (GLOBE NEWSWIRE) -- The "Global Drug Eluting Balloons (DEBs) Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The drug eluting balloons (DEBs)...
Injectable Drug Delivery Market to Reach USD 1,251.28 Billion by 2027 Accountable to Increasing Adoption of Minimally Invasive Treatment Methods, says Fortune Business Insights™
July 21, 2020 10:04 ET
|
Fortune Business Insights
Pune, July 21, 2020 (GLOBE NEWSWIRE) -- The global injectable drug delivery market is anticipated to rise at a CAGR of 12.9% to reach USD 1,251.28 billion by the end of 2027 owing to the increasing...
NOVA Thin Film Pharmaceuticals and Quality Chemical Laboratories Announce Partnership in Formation and Commencement of Soluble Thin Film Operations
June 01, 2020 08:00 ET
|
Nova Thin Film Pharmaceuticals
GREENSBORO, N.C., June 01, 2020 (GLOBE NEWSWIRE) -- NOVA Thin Film Pharmaceuticals LLC (NTFP) announced today its formation and the commencement of its soluble thin film operations. NTFP is...
CURE Pharmaceutical [OTCQB:CURR] Expands Cannabis Extraction Patents, Adding Support for CBG for Therapeutic Solutions
April 21, 2020 07:30 ET
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, April 21, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the issuance of two U.S. Patents: No. 10,639,339...
CURE Pharmaceutical [OTCQB:CURR] Licenses Cannabis Extraction Patents to Vanguard Scientific
February 12, 2020 07:15 ET
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, Feb. 12, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced a licensing and collaboration agreement with...
CURE Pharmaceutical [OTCQB:CURR] Takes First Step to Acquire Coeptis Pharmaceuticals and its Combination Drug for Osteoarthritis Pain and Hypertension
November 14, 2019 07:00 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, today announced that it purchased a $200,000...
CURE Pharmaceutical [OTCQB:CURR] Debuts CUREform Drug Delivery Line Adding Chewables and Emulsions
October 09, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Oct. 09, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, announces the expansion of its oral drug delivery product line...
CURE Pharmaceutical [OTCQB:CURR] Secures Patent on High Loading of Active Ingredient in Oral Thin Films
July 24, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of U.S. Application No....
CURE Pharmaceutical [OTCQB:CURR] Secures Patent on Oral Thin Films With Bi-Phasic Release of Natural Ingredients
July 16, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of U.S. Application No....